Section 1 of 6
Terms and abbreviations
1 evidence topic · 0 sources
| Abbreviation | Term |
|---|---|
| AAAAI | American Academy of Allergy, Asthma and Immunology |
| AAR | Acute allergic reaction |
| ACE | Angiotensin-converting enzyme |
| AE | Adverse event |
| AHFS | American Hospital Formulary Service |
| APC | Antigen-presenting cell |
| ATC | Anatomical Therapeutic Chemical |
| AUC | Area under the concentration-time curve |
| CEA | Cost-effectiveness analysis |
| CFR | Case fatality rate |
| CI | Confidence interval |
| CMC | Chemistry, manufacturing, and controls |
| COMT | Catechol-O-methyltransferase |
| CRL | Complete Response Letter |
| CV | Cardiovascular |
| CVD | Cardiovascular disease |
| DBP | Diastolic blood pressure |
| DDD | Defined daily dose |
| DESF | Dibutepinephrine sublingual film |
| EAI | Epinephrine auto-injector |
| ED | Emergency department |
| EMA | European Medicines Agency |
| EMS | Emergency medical services |
| EOP2 | End of phase 2 |
| FA | Food allergy |
| FAAN | Food Allergy and Anaphylaxis Network |
| FAIM | Food Allergy Independent Measure |
| FDA | Food and Drug Administration |
| GA2LEN | Global Allergy and Asthma European Network |
| GI | Gastrointestinal |
| HCP | Health care professional |
| HF | Human factors |
| HRQoL | Health-related quality of life |
| ICER | Incremental cost-effectiveness ratio |
| IgE | Immunoglobulin E |
| IgG | Immunoglobulin G |
| IM | Intramuscular |
| IND | Investigational new drug |
| IQR | Interquartile range |
| IV | Intravenous |
| MCDD | Multiple cause of death data |
| MRGPRX2 | Mas-related G protein-coupled receptor X2 |
| NADAC | National Average Drug Acquisition Cost |
| NDA | New drug application |
| NEDS | Nationwide Emergency Department Sample |
| NIAID | National Institute of Allergy and Infectious Diseases |
| NIS | National Inpatient Sample |
| NMB | Net monetary benefit |
| NSAID | Nonsteroidal anti-inflammatory drug |
| OAC | Oral allergen challenge |
| OAS | Oral allergy syndrome |
| OFC | Oral food challenge |
| OHCA | Out-of-hospital cardiac arrest |
| OIT | Oral immunotherapy |
| PAF | Platelet-activating factor |
| PD | Pharmacodynamics |
| PDUFA | Prescription Drug User Fee Act |
| PFAS | Pollen-food allergy syndrome |
| PK | Pharmacokinetics |
| PMH | Past medical history |
| QALD | Quality-adjusted life-day |
| QALY | Quality-adjusted life-year |
| RD | Repeat dose |
| SAD | Single ascending dose |
| SAE | Serious adverse event |
| SBP | Systolic blood pressure |
| SC | Subcutaneous |
| SD | Standard deviation |
| SL | Sublingual |
| SPT | Skin prick test |
| TEAE | Treatment-emergent adverse event |
| TNF | Tumor necrosis factor |
| TRx | Total prescriptions |
| WAO | World Allergy Organization |
| WHO | World Health Organization |